Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Health Sciences Group, Inc. HESG OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
27/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Health Sciences Group, Inc. (HESG) is a Biotechnology company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 25/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Financials: revenue is $358,434, +128.9%/yr average growth. Net income is $54,487 (loss), growing at +34.4%/yr. Net profit margin is -15.2% (negative). Gross margin is 7% (-11.6 pp trend).

Balance sheet: total debt is $320,000 against $595,868 equity (Debt-to-Equity (D/E) ratio 0.54, moderate). Current ratio is 0.31 (tight liquidity). Debt-to-assets is 31%. Total assets: $1M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 100/100 (Pass), Past 0/100 (Fail), Health 25/100 (Fail), Moat 0/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

HESG SharesGrow Score Overview

45/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 25/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — HESG

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
100/100
HESG: +128.9%/yr revenue is, +34.4%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
25/100
Balance sheet HESG: Debt-to-Equity (D/E) ratio 0.54 (moderate), Current ratio is 0.31 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
HESG: Net profit margin is -15.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.0001
Volume1M
Avg Volume (30D)1.71K
Market Cap$1.87M
Beta (1Y)2.71
Share Statistics
Shares Outstanding$18.71B
IPO Date2001-08-06
Employees2
CEOThomas Gaffney
Financial Highlights & Ratios
Revenue (TTM)$358.43K
Gross Profit$25.23K
EBITDA$-44.72K
Net Income$-54.49K
Operating Income$-54.49K
Total Cash$1.38K
Total Debt$320K
Net Debt$318.62K
Total Assets$1.03M
Price / Sales (P/S)5.22
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS42223A1007

Price Chart

Track all markets on TradingView
HESG
Health Sciences Group, Inc.  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.00

People Also View

PHGUF
PHGUF
Pharming Group N.V.
$1.75
+15.89%
 MMIRF
MMIRF
MedMira Inc.
$0.05
+0.00%
 KNBIF
KNBIF
Kane Biotech Inc.
$0.02
-3.64%
 OCTHF
OCTHF
Oxford Cannabinoid Technologies Holdings Plc
$0.00
+0.00%
 NTII
NTII
Neurobiological Technologies, Inc.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message